Skip to main content
GYRE logo

GYRE

Gyre Therapeutics, Inc.
$7.34 +0.82 (+12.58%) At close · Jul 2
Market Cap
$712.19M
Shares
97,028,322

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 55
Total Value: $23,262,133
Total Shares: 3,337,471

Institutional Ownership Trend

11 quarters

Holder Concentration

Across 55 13F filers
Top Holder
29.5%
Dec 2023 → Mar 2026 · range 23.9% – 42.0%
of institutional value
Top 5
76.7%
Dec 2023 → Mar 2026 · range 76.7% – 92.3%
of institutional value
Top 10
93.3%
Dec 2023 → Mar 2026 · range 92.8% – 99.8%
of institutional value
HHI
1,689
Dec 2023 → Mar 2026 · range 1,555 – 2,435
Moderately concentrated
Showing 55 of 55
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1124105 CUSIP 403783103 13F (30d) 1 filings 1 filers Visit website Investor relations